Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT07550504
What this trial is testing

Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion With Macular EdemaCentral Retinal Vein Occlusion With Macular Edema+1 more
Samsung Bioepis Co., Ltd. 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04101877
What this trial is testing

The Sahlgrenska Anti-VEGF Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Vastra Gotaland Region 402
Very early researchUnknownNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Not applicableEnded earlyNCT00474695
What this trial is testing

Study Evaluating Genotypes Using Lucentis

Who this might be right for
Age-Related Maculopathy
University of Utah 65
Early research (Phase 1)Study completedNCT00782093
What this trial is testing

Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 63
Post-approval studies (Phase 4)Study completedNCT02257632
What this trial is testing

Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT03197493
What this trial is testing

Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Macula; DegenerationRetina
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01103505
What this trial is testing

HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome Device

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 1,520
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT05275205
What this trial is testing

Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)

Who this might be right for
Neovascular Age-related Macular Degeneration
Unity Biotechnology, Inc. 51
Post-approval studies (Phase 4)UnknownNCT03468296
What this trial is testing

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept

Who this might be right for
Neovascular Age-related Macular Degeneration
Tennessee Retina 22
Not applicableLooking for participantsNCT07005323
What this trial is testing

Progression Suppression and Retinal Regression in VEGF-resistant AMD

Who this might be right for
Neovascular Age-related Macular Degeneration (AMD)
PharmaBio Corporation 10
Testing effectiveness (Phase 2)Study completedNCT03023059
What this trial is testing

Dose Ranging Study of Carbidopa-levodopa

Who this might be right for
Age-related Macular Degeneration
Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01334294
What this trial is testing

Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Age Related Macular DegenerationChoroidal Neovascularization
Notal Vision Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973
What this trial is testing

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Who this might be right for
Neovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 69
Large-scale testing (Phase 3)WithdrawnNCT05126966
What this trial is testing

The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Hoffmann-La Roche
Early research (Phase 1)Study completedNCT02859766
What this trial is testing

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Allergan 30
Not applicableNot Yet RecruitingNCT07088445
What this trial is testing

Therapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
Hui Peng 35
Large-scale testing (Phase 3)UnknownNCT05297292
What this trial is testing

Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

Who this might be right for
Wet Age-related Macular Degeneration
Mabwell (Shanghai) Bioscience Co., Ltd. 433
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660667
What this trial is testing

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Sanofi 66
Next Page